Merus Announces Pricing of Upsized Public Offering of Common Shares
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 -- Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the...